| NCT ID | NCT07571564 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut Curie |
| Condition | Enteral Nutrition |
| Study Type | OBSERVATIONAL |
| Enrollment | 80 participants |
| Start Date | 2026-03-05 |
| Primary Completion | 2027-09-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 80 participants in total. It began in 2026-03-05 with a primary completion date of 2027-09-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Malnutrition is a major challenge in cancer nutrition, affecting approximately 40% of cancer patients and having negative consequences on treatment efficacy, quality of life, and prognosis. It must be detected and managed early, based on clinical and laboratory criteria defined by the HAS recommendations. To address this, several nutritional strategies are available, ranging from fortified oral feeding to artificial nutrition. Enteral nutrition, which is more physiological and carries fewer risks than parenteral nutrition, is recommended as the first-line treatment. Tools such as personalized care plans and guidelines help tailor patient care. However, enteral nutrition remains underutilized in clinical practice, despite the recommendations. The ADHENUTE study, conducted at the Institut Curie, showed low compliance with recommendations (31%) and a tendency to favor oral nutritional supplements, even in severely malnourished patients. The lack of traceability of decisions makes it difficult to identify barriers, although patient refusal is sometimes mentioned. To improve this situation, corrective measures have been implemented: * for patients, through educational workshops to help them better understand and accept enteral nutrition; * for healthcare providers, through training sessions to address reservations and enhance knowledge. A third phase of the study aims to evaluate the impact of these actions, with the goal of increasing adherence to recommendations and the use of enteral nutrition.
Eligibility Criteria
Inclusion Criteria: * Patients hospitalized (including those in the day hospital) in a medical oncology unit; * Adults; * Men or women; * Patients for whom enteral nutrition is indicated according to SFNCM recommendations; Exclusion Criteria: * Minors (under 18 years of age) * Patients receiving end-of-life palliative care * Individuals deprived of their liberty or under legal guardianship (including conservatorship); * Adults under judicial protection; * Inability to participate in the study for geographical, social, or psychological reasons. * Persons referred to in Articles L. 1121-5 through L. 1121-8 and L. 1122-1-2 of the Public Health Code (e.g., minors, adults under guardianship, etc.). * Patients who do not speak or understand French.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07571564 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Enteral Nutrition. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07571564 currently recruiting?
Yes, NCT07571564 is actively recruiting participants. Contact the research team at betty.peignelin@curie.fr for enrollment information.
Where is the NCT07571564 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT07571564 clinical trial?
NCT07571564 is sponsored by Institut Curie. The trial plans to enroll 80 participants.